ERBB2 and breast carcinoma: Particularly, triple-negative breast cancers (TNBCs) lacking the expression of the (ER), (PR) and (HER-2) represent the major cause of breast cancer mortality due to their metastatic potential, invasiveness and the lack of suitable molecular treatment targets [6,7,8].